aPKC alters the TGFβ response in NSCLC cells through both Smad-dependent and Smad-independent pathways

Journal of Cell Science
|December 16, 2014
PubMed

Insights

aPKC inhibition reduces TGFb-dependent gene expression in NSCLC cells by disrupting Smad nuclear translocation. This leads to increased apoptosis via p38 MAPK and TRAF6 signaling, suggesting aPKC as a therapeutic target.

Area of Science:

  • Cellular Biology
  • Molecular Signaling
  • Cancer Research

Background:

  • Transforming growth factor beta (TGFb) signaling is crucial for cellular functions, involving both canonical (Smad) and non-canonical pathways.
  • Previous research indicated that atypical protein kinase C (aPKC) inhibition affects TGFb receptor trafficking and signaling.

Purpose of the Study:

  • To investigate the role of aPKC in regulating TGFb signaling pathways in non-small cell lung cancer (NSCLC).
  • To elucidate how aPKC silencing impacts TGFb-dependent transcriptional responses and apoptosis in NSCLC cells.

Main Methods:

  • Silencing of aPKC in NSCLC cells.
  • Assessment of TGFb-dependent transcriptional responses.
  • Analysis of Smad2 phosphorylation, SARA–Smad2–Smad4 association, and Smad2 nuclear translocation.
  • Evaluation of p38 MAPK phosphorylation and apoptosis, including TRAF6 dependency.

Main Results:

  • aPKC silencing reduced TGFb-dependent gene expression despite prolonged Smad2 phosphorylation.
  • Knockdown of aPKC increased SARA levels and SARA–Smad2 complex formation, impairing Smad2–Smad4 association and nuclear translocation.
  • Increased p38 MAPK phosphorylation and apoptosis were observed in aPKC-silenced cells, dependent on TRAF6.

Conclusions:

  • aPKC isoforms regulate both Smad and non-Smad TGFb signaling pathways.
  • Inhibition of aPKC sensitizes NSCLC cells to TGFb-induced apoptosis, highlighting a potential therapeutic strategy.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.9K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K